B S D M E D I C A L
A company specializing in BioSystems Design
Table of Contents
BSD Medical Corporation • The Hyperthermia Company
- Patients
- Physicians
- Investors
- investors_files/filelist.xml
- Financial Statements
- Market Makers
- Links Page
- BSD on the Web
- Ethics
- Disclaimer
- Advances
- Press Releases
- BSD Medical Signs Best Medical International as U.S. Sales Agent
- NYU Cancer Center Features New System by BSD Medical
- Press Release 10/13/04
- BSD Medical Corp. Sponsors Symposium and Displays Products at ASTRO
- BSD Medical Corp. Enters China Market through Agreement with Dalian Orientech
- BSD Medical Corporation Unveils Its Prime Initiatives Following Major Cash Infusion
- BSD Medical Corporation Concludes the Sale of Its Holdings in TherMatrx, Inc.
- BSD Medical Corporation Comments on the Sale of Its Holdings in TherMatrx, Inc.
- BSD Medical Corporation Sells Its Holdings in TherMatrx, Inc.
- BSD Medical’s Hyperthermia Systems—Patient Friendly Treatment for Rectal Cancer
- BSD Medical Receives FDA Approval to Investigate New Cancer Treatment Applicator
- TherMatrx Receives New FDA Approval - New Catheter Expands Patient Group for Dose Optimized Thermotherapy
- BSD Medical’s Chairman Nominated for “Entrepreneur of the Year”
- BSD Medical to Present Major Technology Advances at World Hyperthermia Conference
- Hyperthermia and Chemotherapy Combo Winning Against Cancer in Germany
- BSD Medical Receives New FDA Approval—Targets Better Treatment of Prostate, Breast and Cervical Cancer
- GYN Cancer--Hot Target for New System by BSD Medical
- Prime Time Television Introduces BSD Medical’s Technology in New Super-Therapy for Cancer
- Prime Time German Television to Feature BSD Medical’s Groundbreaking Cancer Therapy
- Medical Reimbursement for TherMatrx BPH Therapy Increased by 50%
- BSD Medical Corporation Raises $2 Million in Private Placement
- Swiss Government Opens the Way to Commercialization of the BSD-2000
- Long Beach Memorial Débuts BSD Medical’s Newly FDA Approved Cancer Treatment System
- BSD Medical Announces FDA Approval of New Cancer Treatment Systems at National Conference
- BSD Medical Receives FDA Approval for New Systems Used in Cancer Treatment
- BSD Medical Technology Opens Exploration into New Super-Therapy for Cancer
- BSD Medical’s Innovative Technology Could Spare ‘the Majority’ of Limb Cancer Patients from Amputation
- BSD Medical Adds a Powerful Punch to Cervical Cancer Treatment
- BSD Medical Corp. Receives High Marks in Routine FDA Audit
- Microwaves Help Children Beat the Odds in Cancer Survival
- New cancer treatment system “sees” temperatures to within half a degree
- BSD Medical Announces Fourth Quarter Net Income of $294,559
- Researchers Observe “Mitotic Catastrophe” in Cancer after Hyperthermia
- BSD Medical Introduces New Cancer Treatment Systems at Three Medical Conferences
- BSD Medical Appoints Three Directors to Audit Committee
- Lancet Oncology Review—Combining Hyperthermia with the Major Cancer Therapies
- Grand Opening Unveils ‘New Form of Cancer Treatment’ Intensifying the Effect of Chemotherapy and Radiation
- TherMatrx Sales Run Away from the Competition
- Nucletron and BSD Medical team up in war against cancer
- BSD Medical Acquires Additional FDA Approval
- BSD Medical Acquires NIH License Rights Following Success with MRI Treatment Monitoring
- TherMatrx Sales Explode—BSD Medical Supplies Hundredth BPH System
- BSD Medical Corporation Announces Quarterly/Year-End Results Fourth Quarter Net Income at 21% of Sales
- BSD Medical’s new MRI-integrated cancer therapy welcomed by Japanese
- Hyperthermia and hypoxia spell cancer destruction—THE LANCET
- BSD Medical Honored by Double Distinctions
- BSD Medical Corporation Announces Third Quarter Earnings Net Income Posted at 25% of Sales
- TherMatrx Receives FDA Approval for New BPH Therapy
- ASCO Presentations Show Hyperthermia Enhances Cancer Drug Delivery
- NAHS Conference Projects ‘Resurgence’ for Hyperthermia
- Erlangen University Joins Prestigious Team of BSD-2000 Based Hyperthermia Treatment Centers
- BSD Medical Introducing Dynamic New Use for MRI
- March Reader’s Digest Features Hyperthermia as “Hot Cancer Regimen”
- Chicago Tribune Lauds Prostate Cancer Treatment Development with BSD-2000
- World Review by Leading Researchers Reports Progress of Hyperthermic Oncology
- Study Offers New Breakthrough for Cancer Patients
- Hyperthermia Holds New Hope for Victims of Rectal Cancer
- BSD Medical Issues Fiscal 2000 Year End Report
- BSD Medical Broadcasts Hyperthermia at National Radiation Oncology Convention
- BSD Medical Places BSD 2000 in 3 Prominent European Facilities
- TherMatrx, Inc. Comments on Recently Announced HCFA Levels for Transurethral Microwave Thermotherapy
- Duke Receives $18 Million Hyperthermia Grant—Six of Nine Protocols Use BSD-2000
- BSD Medical Releases Third Quarter Results
- BSD Hires Investor Relations Firm
- BSD Medical Sees Clinton’s Medicare Order as Boon for Small Biotech Firms
- BSD Medical Corporation’s Third Quarter Sales Top $865,000
- BSD Medical Hires Dr. Mark Hagmann, Reports on Need for Expansion
- BSD Medical Plays Prominent Role in World Hyperthermia Congress
- BSD Medical Receives FDA Approval for Ovarian Cancer Study at Duke University
- THE LANCET Reports Six Year Study Showing Success in Treating Cervical Cancer--Trials Used BSD-2000 Deep Regional Hyperthermia System
- BSD Medical Emphasizes Scope of EORTC Cancer Research
- BSD Medical Announces Quantum Advance in 3D Hyperthermia Control
- Ovarian Cancer Targeted by Duke University Liposome Study Using BSD-2000
- Duke University Joins EORTC in Phase III Trials Using the BSD-2000
- BSD Medical Shares Up 1500%—Issues Eighteen Month Milestone Report
- National Television Introduces BSD Medical and Hyperthermia to America
- National Television to Feature BSD Medical and Hyperthermia
- Duke University Studies Define the Therapeutic Role of Hyperthermia
- BSD Announces Receipt of CE Mark for Proprietary BSD-2000/3D System
- Duke University Reports Progress in Treating Sarcomas with BSD Equipment
- Backlog Surges for BSD Medical Corporation
- BSD Hires Director of U.S. Sales
- BSD Medical Acquires Exclusive License to Tumor-Destroying Hyperthermia Treatment
- CNBC (Paid Program) to Feature Hyperthermia as a "Powerful Tool" in Cancer Treatment
- Hyperthermia Makes Radiation and Chemotherapy More Effective
- Hyperthermia Reimbursed as First Line Therapy for Cervical Cancer
- BSD Medical Corporation Announces Appointment of New President
- BSD Medical Corporation Announces BSD-2000/3D Deep Hyperthermia System Shipment to Rotterdam, The Netherlands
- BSD’s Hyperthermia Equipment Provides Optimum Performance - Data Reported at North American Hyperthermia Society Meeting
- BSD Medical Announces Clinical Acceptance of Noninvasive Hyperthermia Cancer Treatment and Monitoring
- BSD Medical Announces Second $3.25 Million Capital Infusion Into TherMatrx
- BSD Appoints Dr. Bill Williams as Director of Marketing and Sales
- European Patent Issued to BSD for New Cancer Treatment Device
- Profile
- Utah Business
- Table of Contents
- Search page
- Feedback Page